Improved Dissolution and Pharmacokinetics of Abiraterone through KinetiSol<sup>®</sup> Enabled Amorphous Solid Dispersions
Abiraterone is a poorly water-soluble drug. It has a high melting point and limited solubility in organic solvents, making it difficult to formulate as an amorphous solid dispersion (ASD) with conventional technologies. KinetiSol<sup>®</sup> is a high-energy, fusion-based, solvent-free t...
Saved in:
Main Authors: | Urvi Gala (Author), Dave Miller (Author), Robert O. Williams (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Melt Fusion Techniques for Solubility Enhancement: A Comparison of Hot Melt Extrusion and KinetiSol<sup>®</sup> Technologies
by: Srinivas Ajjarapu, et al.
Published: (2022) -
How Does the Addition of Kollidon<sup>®</sup>VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions?
by: Joanna Szafraniec-Szczęsny, et al.
Published: (2021) -
The Amorphous Solid Dispersion of Chrysin in Plasdone<sup>®</sup> S630 Demonstrates Improved Oral Bioavailability and Antihyperlipidemic Performance in Rats
by: Chenhui Wang, et al.
Published: (2023) -
Oral Delivery of Niclosamide as an Amorphous Solid Dispersion That Generates Amorphous Nanoparticles during Dissolution
by: Miguel O. Jara, et al.
Published: (2022) -
Development and Characterization of Eudragit<sup>®</sup> EPO-Based Solid Dispersion of Rosuvastatin Calcium to Foresee the Impact on Solubility, Dissolution and Antihyperlipidemic Activity
by: Sana Inam, et al.
Published: (2022)